Pancreatic cancer & chemotherapy for pancreatic cancer

Pancreatic adenocarcinoma, an exocrine tumour creating from the cells lining the pancreatic duct, is the most prevalent kind of pancreatic cancer. Less than 5% of pancreatic cancers are endocrine tumours, an abundant less frequent variety also known as neuroendocrine or islet cell tumours.

Pancreatic cancer chemotherapy although the key treatment for pancreatic cancer is surgery, many individuals are originally inoperable since the disease has previously spread to their blood vessels. At the Pancreas Center, we use chemotherapy and radiation therapy to decrease tumour size and are able to do surgery on a huge number of patients with locally incurable pancreatic cancer who would not otherwise have a chance at recovery. Each patient's choice to have chemotherapy prior to surgery is complicated, and the surgeons, medical oncologists, radiation oncologists, radiologists, gastroenterologists, and others think through it in a multidisciplinary conference.

    Related Conference of Pancreatic cancer & chemotherapy for pancreatic cancer

    September 26-27, 2024

    7th Annual Congress on Emergency Medicine and Acute Care

    Amsterdam, Netherlands
    October 31-01, 2024

    8th International Conference on Internal Medicine

    Amsterdam, Netherlands
    November 22-23, 2024

    4th International Conference on Medical Research and Development

    Aix-en-Provence, France
    November 25-26, 2024

    10th World Congress on Anesthesia and Critical Care

    Paris, France
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Aix-en-Provence, France

    Pancreatic cancer & chemotherapy for pancreatic cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in